Scientists studying depression in teens have discovered that subtle changes in a gene can predict how the brain reacts to stress, which can cause such health issues as depression, post-traumatic stress disorder and obesity. The research focuses on two longitudinal studies from The University of Texas and Duke University. Scientists from Columbia University and the University of Pittsburgh are also involved in the research.
Scientists have believed that the tendency to develop stress-related disorders is an inherited trait or is the result of exposure to traumatic events. In this paper, the researchers are also looking into another factor, that genes may change over time, making some individuals with the same genetic makeup more susceptible to stress than others.
In these studies the researchers looked at the serotonin transporter, a gene that regulates the amount of serotonin signalling that occurs between brain cells and is frequently the target for antidepressant drugs. They proved the existence of a mechanism impacting the brain that also may play a role in an individual’s reaction to stress, which may be a stronger predictor of stress than DNA sequencing. They used Functional magnetic resonance imaging (fMRI), saliva tests, blood tests, and examination of brain tissue from deceased individuals to validate their theory.
Attached to the serotonin transporter’s DNA are chemical marks called methyl groups that help regulate when, where and how much of the gene is expressed. DNA methylation (the chemical marks) are one form of gene modification, which scientists are studying to understand how the same genetic code can produce a wide range of cellular responses in the body, as well as differences in individuals’ reaction to stress.
Varying the DNA sequence in this gene has been shown to predict activation in the amygdala and is linked with depression, so the researchers were interested in determining if DNA methylation may be playing a role in regulating how the brain responds to stress, ultimately making an individual vulnerable to stress-related disorders like depression.
The amygdala is a region in the temporal lobe of the brain that helps shape behavioural and biological responses to threat and stress.
Initially, the team performed imaging of the brains of 80 participants. Students were shown angry or fearful faces and researchers recorded their responses in the amygdala. The team also measured the amount of methylation on serotonin transporter DNA from the participants’ saliva. To the researchers’ surprise, even small changes in methylation corresponded with amygdala activity and appeared to be a better predictor of the risk of depression than DNA sequence variation.
To extend and replicate the initial findings, the team examined brain images and DNA in 96 adolescents ages 12 to 15 participating in the Teen Alcohol Outcomes Study (TAOS), a different long-term study led by the team. Researchers again measured amygdala reactivity to angry or fearful faces as well as methylation of the serotonin transporter gene this time in participants’ blood. The analyses revealed an even stronger link between methylation and amygdala reactivity.
To determine if their findings were occurring directly in the amygdala the group analyzed DNA methylation patterns and gene expression in the brains of people who had passed away. To the group’s surprise, they received the exact same results. The methylation sites on the fMRI images corresponded perfectly with lower levels of the serotonin transporter expression in the amygdala. Methylation was suppressing the expression of the gene.
The fact that methylation patterns were the same in saliva, blood and the brain suggests that these patterns, at least in the case of the serotonin transporter, may be passed down through generations. However, it is also possible that exposure to stress over time impacts changes in methylation systematically throughout the body.
The findings of the current study and the team’s ongoing research are contributing to a paradigm shift in how the medical community examines genetic contributions to psychiatric conditions like depression and posttraumatic stress disorder. The researchers are moving beyond simple inherited genetic sequence variation to examine what is being modified during one’s lifetime and how this may in turn be passed on to a person’s children.
The work is helping to identify the specific mechanisms that are involved in the onset of depression, which is involved in 70 percent of people with PTSD. Ultimately, the team hope that their findings will lower the risk of developing depression and other stress-related disorders in the future.
amygdala, biomarker, depression, DNA methylation, epigenetics, fMRI, gene sequencing, genetics, healthinnovations, neurobiology, neurogenesis, neuroimaging, neuroinnovations, neurology, neuropsychiatry, neuroscience, neurotransmission, PTSD, serotonin, stress
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.